CAREDX
CareDx is a molecular diagnostics company based in Brisbane, CA, USA. XDx applies modern genomics technologies to the development of molecular diagnostic assays that translate a patient's immune status into clinically actionable information. XDx has one marketed product, AlloMap Molecular Expression Testing, and other products under development. The proprietary molecular expression technology used by XDx to develop AlloMap testing for heart transplant patient management may be applicable to the post-transplant management of recipients of other organs. The application of gene expression testing to other diseases that involve the activity of the immune system, such as autoimmune and chronic inflammatory diseases, is also being explored.
CAREDX
Industry:
Biotechnology Genetics Health Care Health Diagnostics
Founded:
2000-01-01
Address:
Brisbane, California, United States
Country:
United States
Website Url:
http://www.caredx.com
Total Employee:
101+
Status:
Active
Contact:
(415) 287-2300
Total Funding:
574.89 M USD
Technology used in webpage:
SPF LetsEncrypt Microsoft Exchange Online Office 365 Mail IPv6 COVID-19 Vimeo Mobile Optimized FLoC Opt-Out FLoC
Similar Organizations
PositiveID
PositiveID is a life science and technology company.
Current Advisors List
Board_member
2020-01-01
Board_member
Board_member
Board_member
2011-01-01
Board_member
2000-01-01
Board_member
Board_member
Board_member
2014-04-01
Current Employees Featured
Marica Grskovic Head of Cell Transplant Therapy @ CareDx
Head of Cell Transplant Therapy
2020-01-01
Peter Maag CEO @ CareDx
CEO
2020-01-01
Mark Collins Sr Director, Client Relationship & Strategy @ CareDx
Sr Director, Client Relationship & Strategy
2021-01-01
Robert Woodward Sr. Vice President, Research and Development @ CareDx
Sr. Vice President, Research and Development
2019-05-01
David Chernoff Chief Medical Officer @ CareDx
Chief Medical Officer
Sean Grant Vice President, Corporate Strategy & Business Development @ CareDx
Vice President, Corporate Strategy & Business Development
2020-05-01
Founder
Stock Details
Acquisitions List
| Date | Company | Article | Price |
|---|---|---|---|
| 2021-11-10 | MedActionPlan | MedActionPlan acquired by CareDx | N/A |
| 2021-06-08 | Transplant Hero | Transplant Hero acquired by CareDx | N/A |
| 2021-03-17 | BFS Molecular | BFS Molecular acquired by CareDx | N/A |
| 2021-01-08 | TransChart | TransChart acquired by CareDx | N/A |
| 2019-08-28 | XynManagement | XynManagement acquired by CareDx | N/A |
| 2019-04-25 | OTTR Chronic Care Solutions | OTTR Chronic Care Solutions acquired by CareDx | 16 M USD |
| 2015-12-16 | Allenex | Allenex acquired by CareDx | 35 M USD |
| 2014-05-27 | ImmuMetrix | ImmuMetrix acquired by CareDx | N/A |
Investors List
Armentum Partners
Armentum Partners investment in Debt Financing - CareDx
Oxford Finance LLC
Oxford Finance LLC investment in Debt Financing - CareDx
Silicon Valley Bank
Silicon Valley Bank investment in Debt Financing - CareDx
GE Capital
GE Capital investment in Grant - CareDx
Kleiner Perkins
Kleiner Perkins investment in Series G - CareDx
DAG Ventures
DAG Ventures investment in Series G - CareDx
Intel Capital
Intel Capital investment in Series G - CareDx
Burrill & Company
Burrill & Company investment in Series G - CareDx
New Leaf Venture Partners
New Leaf Venture Partners investment in Series G - CareDx
Sprout Group
Sprout Group investment in Series G - CareDx
Investments List
| Date | Company | Article | Money raised |
|---|---|---|---|
| 2021-05-28 | Miromatrix Medical | CareDx investment in Series C - Miromatrix Medical | N/A |
Official Site Inspections
http://www.caredx.com Semrush global rank: 1.82 M Semrush visits lastest month: 12.46 K
- Host name: host.caredx.com
- IP address: 206.72.199.212
- Location: Secaucus United States
- Latitude: 40.7876
- Longitude: -74.06
- Metro Code: 501
- Timezone: America/New_York
- Postal: 07094
More informations about "CareDx"
Company | CareDx
Launched first commercial product, AlloMap ® Heart, in 2005, now used by over 90% of U.S. transplant centers; Launched second surveillance product, AlloSure ®, in 2017, using dd …See details»
Corporate Responsibility & Patient Advocacy - CareDx
We also have a Diversity, Equity, and Inclusion (DEI) Committee. Our goal is to ensure CareDx is a place where all feel welcome and where everyone feels like they have a voice. Our DEI mission is to engage, retain, and develop talent …See details»
CareDx - Crunchbase Company Profile & Funding
Organization. CareDx . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. About. CareDx provides …See details»
CareDx
A site for securely managing CareDx testing orders, patient information, transplant information, patient results, and reporting.See details»
CareDx, Inc. - EverybodyWiki Bios & Wiki
CareDx is a US biotechnology firm, located in Brisbane, California, specializing in pre and post-transplant surveillance care. The company was founded by Peter Altman in 1998 and focuses …See details»
CareDx - transplantfamilies.org
CareDx is looking for a group of transplant patients to serve as Patient Ambassadors, helping educate others about the transplant journey. As an ambassador, you will have the opportunity …See details»
CAREDXHEALTH.COM
Look for CareDx at the following events: ITNS Annual Symposium 2018 Chicago, IL, United States September 28-30, 2018. ASHI 44th Annual Meeting 2018 Baltimore, MD, United States …See details»
CareDx - 2025 Company Profile, Funding & Competitors - Tracxn
Mar 21, 2025 CareDx. has raised a total funding of $103M over 13 rounds. Its first funding round was on Apr 2004. What are the most recent funding rounds of CareDx? Its latest funding …See details»
CareDx Partners with the North American Pediatric Renal Trials …
Dec 13, 2021 CareDx offers testing services, products, and digital healthcare solutions along the pre- and post-transplant patient journey and is the leading provider of genomics-based …See details»
CareDx Partners with HeartBrothers Foundation to Help Patients …
Mar 29, 2022 SOUTH SAN FRANCISCO, Calif., March 29, 2022 (GLOBE NEWSWIRE) - CareDx, Inc. (Nasdaq: CDNA) – The Transplant Company™ focused on the discovery, …See details»
Careers | CareDx
To ensure reasonable accommodation are provided to individuals protected by Section 503 of the Rehabilitation Act of 1973, the Vietnam Era Veterans’ Readjustment Act of 1974, and Title I of …See details»
CareDx Launches Two Expanded Indications for AlloSure Testing …
These statements are also subject to general economic and market factors, and global economic and marketplace uncertainties, among other risks discussed in CareDx’s filings with the …See details»
CareDx Company Profile - Office Locations, Competitors, Revenue …
Oct 29, 2024 CareDx has 5 employees across 6 locations and $333.79 m in annual revenue in FY 2024. See insights on CareDx including office locations, competitors, revenue, financials, …See details»
CareDx - Contacts, Employees, Board Members, Advisors
CareDx provides transplant lab products. New. Resources. Advanced Search. Start Free Trial . Talk With Sales ... Experience the new Crunchbase, powered by AI . Experience the new …See details»
Login - CareDx
Offers online access to the CareDx patient services team to efficiently locate, schedule, and arrange blood draws, including mobile phlebotomy services. CarePortal Login. Digital Health …See details»
CareDx Enhances Leadership Team with Key Appointments
Mar 31, 2021 CareDx is also pleased to announce the promotion of the following two leaders who have made a significant impact on the organization. Marica Grskovic, Ph.D., has been …See details»
CareDx Inc Company Profile - Overview - GlobalData
CareDx Inc (CareDx) is a leading precision medicine company that focuses on the discovery, development and commercialization of clinically differentiated, high-value diagnostic solutions …See details»
Leidos teams with CareDx to transform the Organ Procurement …
(RESTON, Va.) January 24, 2025 – Leidos (NYSE: LDOS) today announced its collaboration with CareDx – The Transplant Company ™ (Nasdaq: CDNA) to help drive one of the most …See details»
CareDx Announces Fourth Quarter and Full Year 2024 Financial …
Dec 31, 2024 Full Year 2024 Revenue Grew 19% to $334 Million Expects Full Year 2025 Revenue of $365 Million to $375 Million CareDx, Inc. (Nasdaq: CDNA) today reported financial …See details»
CareDx Advances Artificial Intelligence in Transplantation
Jun 3, 2021 Together, CareDx and OrganX will develop advanced analytics that integrate AlloSure, the first transplant specific dd-cfDNA assay, with large transplant databases to …See details»